APArash Panahifar

Arash Panahifar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Arash Panahifar has a total of 146 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    DanMAX – a beamline for materials science using powder X-ray diffraction, total scattering, and full-field tomographic imaging

    by Mads Ry Vogel Jørgensen, Innokenty Kantor, Frederik Holm Gjørup, Daniel Riskov Sørensen, Thorbjørn Erik Køppen Christensen, Hari Narayanan Vasavan, Arash Panahifar, Silvia Forcat, Erik Bergbäck Knudsen, Marcelo J. P. Alcocer, et al.

    DanMAX is a hard X-ray materials science beamline at the ultra-low emittance 3 GeV storage ring at the MAX IV laboratory. It is designed for performing in situ and in operando studies using powder X-ray diffraction and full-field imaging. The beamline is equipped with an in-vacuum undulator source providing photons in the energy range 15–35 keV. The beam can be focused using compound refractive lenses, thus providing a variable beam size range from approximately 15 µm to 1.2 mm (FWHM) that can be changed in seconds. This paper presents the X-ray optics, discusses its performance, and shows the first endstation instrument for powder X-ray diffraction, available sample environments, and the surrounding infrastructure. The powder diffraction instrument is equipped with a CdTe hybrid pixel detector for powder X-ray diffraction and total scattering, as well as an energy-resolved silicon drift detector for X-ray fluorescence experiments. The instrument and infrastructure are designed to be highly flexible to accommodate various sample environments for in situ and in operando experiments.

  • Analysis of Landmark-Based Coordinates for Mouse Intracerebroventricular Surgery Using In Vivo X-Ray Microtomography

    by Mattia Humbel, Christine Tanner, Hans Deyhle, Marta Girona Alarcón, Britta Bausch, Willy Kuo, Petr Pleskač, Arash Panahifar, Sergey Gasilov, Britta Engelhardt, et al.

  • Open Access

    Oxidative stress-induced intervertebral disc remodelling and elevated stiffness drive idiopathic scoliosis in preclinical models

    by Patrick G. Pumputis, Ran Xu, Josh Gopaul, Arash Panahifar, Vida Erfani, Jenica L. M. Van Gennip, B. Frank Eames, Nikan Fakhari, Jerome Baranger, David E. Lebel, et al.

    Adolescent idiopathic scoliosis (AIS) is the most prevalent pediatric spine disorder, developing in the absence of obvious physiological defects. Genome sequencing and functional studies have demonstrated association of musculoskeletal collagen variants and cartilaginous extracellular matrix (ECM) defects in a subset of patients. However, the underlying biological causes of AIS remain poorly understood, limiting treatment options. Using multiple zebrafish AIS models, we demonstrate that reduction-oxidation (redox) imbalances induce cell stress and collagen remodelling within intervertebral segments of the developing spine. Mutant spines are consequently stiffer, as measured by shear wave elastography, and exhibit deformations of intervertebral structures. Remarkably, elevated stiffness and intervertebral ECM phenotypes are detectable prior to scoliosis onset, suggesting a causal relationship, and can be suppressed by antioxidant treatment. Together, our preclinical studies implicate oxidative stress-induced intervertebral deformations in the pathogenesis of AIS and identify elevated spine stiffness and redox imbalance as plausible first-in-kind prognostic biomarkers and therapeutic targets.


  • Open Access

    Oxidative stress induces intervertebral ECM remodelling, elevated tissue stiffness and idiopathic-like scoliosis

    by Brian Ciruna, Patrick Pumputis, Ran Xu, Josh Gopaul, Arash Panahifar, Vida Erfani, Jenica Van Gennip, B Eames, Nikan Fakhari, Jerome Baranger, et al.

    Adolescent idiopathic scoliosis (AIS) is the most prevalent paediatric spine disorder, developing in the absence of obvious congenital or physiological defects. Patient genetic sequencing and mouse functional studies have demonstrated association of musculoskeletal collagen variants and cartilaginous extracellular matrix (ECM) defects in a subset of cases. However, the underlying biological causes of AIS are poorly understood, thus treatment options remain limited to physical bracing or invasive corrective surgery. Here we interrogate the biological causes of scoliosis in zebrafish preclinical models of AIS. We demonstrate that neuroinflammation-associated reduction-oxidation (redox) imbalance induces cell stress and collagen remodelling defects within intervertebral segments of the developing spine. Mutant spines are consequently stiffer, as measured by shear wave elastography, and exhibit deformations of intervertebral structures. Remarkably, both elevated spine stiffness and intervertebral ECM phenotypes are detectable prior to scoliosis onset in zebrafish models, suggesting a causal relationship, and can be suppressed by antioxidant treatment. Together, our studies implicate oxidative stress-induced intervertebral deformations in the pathogenesis of AIS and identify elevated spine stiffness and redox imbalance as plausible first-in-kind prognostic biomarkers and therapeutic targets.

  • Open Access

    Hard X-ray imaging and tomography at the Biomedical Imaging and Therapy beamlines of Canadian Light Source

    by Sergey Gasilov, M. Adam Webb, Arash Panahifar, Ning Zhu, Omar Marinos, Toby Bond, David M. L. Cooper, Dean Chapman

    The Biomedical Imaging and Therapy facility of the Canadian Light Source comprises two beamlines, which together cover a wide X-ray energy range from 13 keV up to 140 keV. The beamlines were designed with a focus on synchrotron applications in preclinical imaging and veterinary science as well as microbeam radiation therapy. While these remain a major part of the activities of both beamlines, a number of recent upgrades have enhanced the versatility and performance of the beamlines, particularly for high-resolution microtomography experiments. As a result, the user community has been quickly expanding to include researchers in advanced materials, batteries, fuel cells, agriculture, and environmental studies. This article summarizes the beam properties, describes the endstations together with the detector pool, and presents several application cases of the various X-ray imaging techniques available to users.


  • Open Access

    Tissue material properties, whole-bone morphology and mechanical behavior in the Fbn1C1041G/+ mouse model of Marfan syndrome

    by Elizabeth A. Zimmermann, Taylor DeVet, Myriam Cilla, Laia Albiol, Kyle Kavaseri, Christine Andrea, Catherine Julien, Kerstin Tiedemann, Arash Panahifar, Sima A. Alidokht, et al.


  • Developing a Microbubble-Based Contrast Agent for Synchrotron In-Line Phase Contrast Imaging

    by Ngoc Ton, Una Goncin, Arash Panahifar, Dean Chapman, Sheldon Wiebe, Steven Machtaler

    X-ray phase contrast imaging generates contrast from refraction of X-rays unlike absorption in conventional radiology. That enhances visualization of soft tissues, often at a reduced absorption radiation. Our goal is to develop a contrast agent for X-ray in-line phase contrast imaging based on ultrasound microbubbles (MBs), by assessing size, shell material, and concentration. We constructed MBs with two different shell materials: phospholipid and polyvinyl-alcohol (PVA). Polydisperse perfluorobutane-core lipid-MBs were size separated using centrifugation into five groups between 1 and 10 μm. We generated two size populations of air-core PVA-MBs, 2 and 3 μm and 3—4 μm, whose shells were either coated or integrated with iron oxide nanoparticles (SPIONs). Microbubbles were then embedded in agar at three concentrations: ${5\times 10^{7}}$ , ${5\times 10^{6}}$ and ${5\times 10^{5}}$ MBs/ml. In-line phase contrast imaging was performed at Canadian Light Source with filtered white beam micro computed tomography. Phase contrast intensity was measured by counting detectable MBs, and comparing the mean pixel values (MPV) in minimum and maximum intensity projections. We can detect lipid-MBs 6-10 μm, lipid-MBs 4-6 μm and PVA-MBs coated with SPIONs at every concentration. With MPV, both lipid-MBs 6-10 μm and 4-6 μm showed an increase in positive contrast at high concentration, whereas only lipid-MBs 6-10 μm showed a significance at moderate concentration. Substantial changes in negative contrast were also seen from two largest lipid-MBs at high concentration. These data indicate that lipid-MBs larger than 4 μm are candidates for in-line phase contrast imaging, and ${5\times 10^{6}}$ MBs/ml may be the lowest concentration suitable for generating visible phase contrast in vivo.


  • Biodistribution of strontium and barium in the developing and mature skeleton of rats

    by Arash Panahifar, L. Dean Chapman, Lynn Weber, Nazanin Samadi, David M. L. Cooper

    Bone acts as a reservoir for many trace elements. Understanding the extent and pattern of elemental accumulation in the skeleton is important from diagnostic, therapeutic, and toxicological perspectives. Some elements are simply adsorbed to bone surfaces by electric force and are buried under bone mineral, while others can replace calcium atoms in the hydroxyapatite structure. In this article, we investigated the extent and pattern of skeletal uptake of barium and strontium in two different age groups, growing, and skeletally mature, in healthy rats. Animals were dosed orally for 4 weeks with either strontium chloride or barium chloride or combined. The distribution of trace elements was imaged in 3D using synchrotron K-edge subtraction micro-CT at 13.5 µm resolution and 2D electron probe microanalysis (EPMA). Bulk concentration of the elements in serum and bone (tibiae) was also measured by mass spectrometry to study the extent of uptake. Toxicological evaluation did not show any cardiotoxicity or nephrotoxicity. Both elements were primarily deposited in the areas of active bone turnover such as growth plates and trabecular bone. Barium and strontium concentration in the bones of juvenile rats was 2.3 times higher, while serum levels were 1.4 and 1.5 times lower than adults. In all treatment and age groups, strontium was preferred to barium even though equal molar concentrations were dosed. This study displayed spatial co-localization of barium and strontium in bone for the first time. Barium and strontium can be used as surrogates for calcium to study the pathological changes in animal models of bone disease and to study the effects of pharmaceutical compounds on bone micro-architecture and bone remodeling in high spatial sensitivity and precision.


  • Bone-targeting parathyroid hormone conjugates outperform unmodified PTH in the anabolic treatment of osteoporosis in rats

    by Yang Yang, Ali Aghazadeh-Habashi, Arash Panahifar, Yuchin Wu, Krishna H. Bhandari, Michael R. Doschak

    Synthetic parathyroid hormone (PTH) is clinically indicated for the treatment of osteoporosis, through its anabolic effects on parathyroid hormone receptors (PTHRs), located on osteoblast cells. However, the bioavailability of PTH for bone cells is restricted by the short half-life of PTH and the widespread distribution of PTHRs in non-skeletal tissues. To impart affinity for mineralized bone surfaces, bisphosphonate (BP)-mediated PTH analogues were synthesized, characterized, and evaluated in vitro and in vivo. The successful synthesis of PTH-PEG-BP was identified on MALDI-ToF mass spectra; bone-targeting potential was evaluated by hydroxyapatite binding test; and receptor bioactivity was assessed in UMR-106 (rat osteosarcoma) cells that constitutively express PTHRs. Therapeutic efficacy was evaluated using ovariectomized rats that remained untreated for 8 weeks to allow development of osteopenia. Those rats then received daily subcutaneous injections of PTH-PEG-BP, thiol-BP vehicle, or unmodified PTH, and compared to sham-operated healthy rats at 0, 4, 8, 12, and 16 weeks. In vivo micro-CT was conducted on the proximal tibial metaphysis to measure microstructural bone parameters, and new bone formation was detected using dynamic labeling. Bone strength was assessed using three-point bending mechanical testing. Our study determined that PTH-PEG-BP conjugates significantly enhanced PTH targeting to the bone matrix while retaining full PTH bioactivity. Moreover, PTH-PEG-BP conjugates significantly increased trabecular bone quality, anabolic bone formation, and improved bone strength over systemically administered PTH alone. We highlight the promise of a novel class of bone-targeting anabolic compound for the treatment of osteoporosis and related bone disorders.


  • Open Access

    La(iii) biodistribution profiles from intravenous and oral dosing of two lanthanum complexes, La(dpp)3 and La(XT), and evaluation as treatments for bone resorption disorders

    by D. M. Weekes, J. F. Cawthray, M. Rieder, J. Syeda, M. Ali, E. Wasan, T. I. Kostelnik, B. O. Patrick, A. Panahifar, A. Al-Dissi, et al.

    Two La3+ containing compounds are tested in vivo as potential oral treatments for osteoporosis.